The <scp>DOAC‐FRAIL</scp> study, evaluation of direct oral anticoagulant‐levels in acutely admitted frail older patients: An exploratory study-Reference-Cited by-同舟云学术

The DOAC‐FRAIL study, evaluation of direct oral anticoagulant‐levels in acutely admitted frail older patients: An exploratory study

Published:2024-03-29 Issue:7 Volume:72 Page:2249-2253
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J American Geriatrics Society

Author:

de Jong Melanie J.¹^ORCID,Saadan Hamza²,Hellenbrand Dave L. S.¹³,ten Cate Hugo¹⁴,Spaetgens Bart²⁴^ORCID,Brüggemann Renée A. G.²⁴,van Kuijk Sander M. J.⁵,Winckers Kristien¹⁴,Henskens Yvonne M. C.¹³,Magdelijns Fabienne J. H.²⁴

Affiliation:

1. Thrombosis Expert Center Maastricht, Heart+Vascular Center, Section of Vascular Medicine Maastricht University Medical Center+ Maastricht The Netherlands

2. Division of General Medicine, Department of Internal Medicine, Section of Geriatric Medicine Maastricht University Medical Center+ Maastricht The Netherlands

3. Department of Clinical Chemistry Maastricht University Medical Center+ Maastricht The Netherlands

4. Division of General Medicine, Department of Internal Medicine, Section of Vascular Medicine Maastricht University Medical Center+ Maastricht The Netherlands

5. Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA) Maastricht University Maastricht The Netherlands

Publisher

Wiley

Reference10 articles.

1. A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

2. Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

3. Testing and monitoring direct oral anticoagulants

4. Aging Biology and Geriatric Clinical Pharmacology

5. Safety of switching from a vitamin K antagonist to a non‐vitamin K antagonist Oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL‐AF randomized controlled trial;Joosten LPT;Circulation,2023